Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 390 | 0 | 0 | 0 | 0 |
| Cost of Goods | 20 | 345 | 342 | N/A | N/A |
| Gross Profit | 370 | -345 | -342 | N/A | N/A |
| Operating Expenses | 8,121 | 5,529 | 3,710 | 3,670 | 4,887 |
| Operating Income | -7,731 | -5,529 | -3,710 | -3,670 | -4,887 |
| Interest Expense | 441 | 316 | 534 | 874 | 590 |
| Other Income | -675 | -605 | -587 | -2,013 | -481 |
| Pre-tax Income | -8,847 | -6,450 | -4,831 | -6,557 | -5,958 |
| Income Tax | 132 | 59 | 60 | 25 | 136 |
| Net Income Continuous | -8,979 | -6,509 | -4,891 | -6,582 | -6,094 |
| Net Income | $-8,979 | $-6,509 | $-4,891 | $-6,582 | $-6,094 |
| EPS Basic Total Ops | -0.20 | -0.16 | -0.14 | -0.20 | -0.30 |
| EPS Basic Continuous Ops | -0.20 | -0.16 | -0.14 | -0.19 | -0.30 |
| EPS Diluted Total Ops | -0.20 | -0.16 | -0.14 | -0.20 | -0.30 |
| EPS Diluted Continuous Ops | -0.20 | -0.16 | -0.14 | -0.19 | -0.30 |
| EPS Diluted Before Non-Recurring Items | -0.20 | -0.16 | -0.14 | -0.12 | -0.30 |
| EBITDA(a) | $-7,376 | $-5,178 | $-3,167 | $-2,834 | $-4,304 |